News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi (France) (SAN.PA) Faces Scrutiny Over What It Plans To Do With Its Cash



2/13/2014 7:34:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

French drugmaker Sanofi will face market scrutiny over what it plans to do with its cash as the prospect of a massive buyback of its shares held by L'Oreal fades. French cosmetics firm L'Oreal and Nestle loosened a 40-year partnership on Tuesday when L'Oreal said it would buy 8 percent of its capital for 6.5 billion euros ($9 billion) from the Swiss food group - but did not need to sell any of its Sanofi shares to fund the deal. L'Oreal thus remains Sanofi's biggest shareholder with a stake of close to 9 percent, worth about $12 billion, and its Chief Executive Jean-Paul Agon told a conference call that L'Oreal was "very happy" with that situation.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES